• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药使用的影响:抗精神病药引起的运动障碍,重点是迟发性运动障碍。

Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.

机构信息

McNeese State University, College of Nursing and Health Professions, 4205 Ryan Street, Lake Charles, LA 70605, USA.

The University of North Carolina at Chapel Hill, School of Nursing, Carrington Hall, CB #7460, Chapel Hill, NC 27599-7460, USA. Electronic address: https://twitter.com/rxseadewPhD.

出版信息

Nurs Clin North Am. 2019 Dec;54(4):595-608. doi: 10.1016/j.cnur.2019.08.004. Epub 2019 Oct 10.

DOI:10.1016/j.cnur.2019.08.004
PMID:31703784
Abstract

Antipsychotics can be life changing, but like all medications, they can also have unwanted effects, including drug-induced movement disorders such as tardive dyskinesia (TD). More patients are receiving antipsychotic treatment from non-psychiatry health care providers, including primary care and general practitioners. Despite misconceptions to the contrary, recent analyses suggest that the risk of drug-induced movement disorders such as TD has not been eliminated. Nurses across all care settings will increasingly encounter patients treated with antipsychotics. Nurses are critical for ensuring that patients exposed to antipsychotics receive screening and monitoring, care, and education.

摘要

抗精神病药可以改变生活,但和所有药物一样,它们也会有不良反应,包括迟发性运动障碍等药物引起的运动障碍。越来越多的患者开始从非精神科医护人员(包括初级保健医生和全科医生)那里接受抗精神病药物治疗。尽管存在相反的误解,但最近的分析表明,迟发性运动障碍等药物引起的运动障碍的风险并未消除。所有护理环境中的护士都将越来越多地遇到接受抗精神病药物治疗的患者。护士对于确保接触抗精神病药物的患者接受筛查和监测、护理和教育至关重要。

相似文献

1
Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.抗精神病药使用的影响:抗精神病药引起的运动障碍,重点是迟发性运动障碍。
Nurs Clin North Am. 2019 Dec;54(4):595-608. doi: 10.1016/j.cnur.2019.08.004. Epub 2019 Oct 10.
2
[Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].抗精神病药物所致迟发性运动障碍的防治
Encephale. 2016 Jun;42(3):248-54. doi: 10.1016/j.encep.2015.12.021. Epub 2016 Feb 26.
3
Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States.美国常规临床护理中使用抗精神病药物的患者出现迟发性运动障碍。
PLoS One. 2019 Jun 4;14(6):e0216044. doi: 10.1371/journal.pone.0216044. eCollection 2019.
4
[Antipsychotic-induced tardive syndromes].[抗精神病药物所致迟发性综合征]
Neuropsychiatr. 2016 Sep;30(3):123-130. doi: 10.1007/s40211-016-0189-7. Epub 2016 Aug 31.
5
Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.用于治疗精神分裂症患者迟发性运动障碍的药物治疗。
Expert Opin Pharmacother. 2017 Jul;18(10):965-972. doi: 10.1080/14656566.2017.1323874. Epub 2017 May 8.
6
Earlier Diagnosis of Tardive Dyskinesia. 早期诊断迟发性运动障碍。
J Clin Psychiatry. 2019 Dec 10;81(1):NU18041BR1C. doi: 10.4088/JCP.NU18041BR1C.
7
The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.精神障碍患者使用抗精神病药物导致迟发性运动障碍的负担。
Curr Med Res Opin. 2019 Jul;35(7):1205-1214. doi: 10.1080/03007995.2019.1569871. Epub 2019 Feb 15.
8
Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia.心境障碍与精神分裂症患者迟发性运动障碍的心理社会影响。
J Clin Psychiatry. 2019 Dec 3;80(6):NU18041BR2C. doi: 10.4088/JCP.NU18041BR2C.
9
Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools.识别迟发性运动障碍:风险因素、功能影响和诊断工具。
J Clin Psychiatry. 2020 Jan 14;81(1):TV18059BR1C. doi: 10.4088/JCP.TV18059BR1C.
10
Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis.精神科患者服用抗精神病药物时 TD 发生率的风险评估和预测:回顾性数据分析。
BMC Neurol. 2019 Jul 20;19(1):174. doi: 10.1186/s12883-019-1385-4.

引用本文的文献

1
Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan.迟发性运动障碍的流行病学和负担的当前观点:对日本临床情况的重点综述
Ther Adv Psychopharmacol. 2022 Dec 26;12:20451253221139608. doi: 10.1177/20451253221139608. eCollection 2022.
2
Pathophysiology, prognosis and treatment of tardive dyskinesia.迟发性运动障碍的病理生理学、预后及治疗
Ther Adv Psychopharmacol. 2022 Oct 21;12:20451253221117313. doi: 10.1177/20451253221117313. eCollection 2022.
3
Contrasting Typical and Atypical Antipsychotic Drugs.
对比典型与非典型抗精神病药物
Focus (Am Psychiatr Publ). 2021 Jan;19(1):3-13. doi: 10.1176/appi.focus.20200051. Epub 2021 Jan 25.
4
-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic.(2-羟苯基)-1-[3-(2-氧代-2,3-二氢-1-苯并咪唑-1-基)丙基]哌啶-4-甲酰胺(D2AAK4),一种多靶点配体的单胺能 GPCR,作为一种潜在的抗精神病药。
Biomolecules. 2020 Feb 24;10(2):349. doi: 10.3390/biom10020349.